Author

C. K. Mok

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

B. A. Ahidjo· 1 shared B. Li· 1 shared C. Chen· 1 shared C. Lin· 1 shared C. Liu· 1 shared D. Y. Wang· 1 shared D. Zhang· 1 shared E. W. Hao· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. A. Ahidjo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 26, 2022

Age-related seroprevalence trajectories of seasonal coronaviruses in children

Y. Luo, H. Lv, S. Zhao…·X. Mu

This study examines age-related seroprevalence of four seasonal coronaviruses in children and postpartum women, showing waning passive immunity and resurgence of IgGs with age.

DOI 10.1101/2022.07.26.501649

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 21, 2020

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

C. K. Mok, Y. L. Ng, B. A. Ahidjo…·J. J. H. Chu

This study identifies calcitriol, the active form of vitamin D, as a potent inhibitor of SARS-CoV-2, suggesting its potential as a prophylactic agent against COVID-19.

DOI 10.1101/2020.06.21.162396

experimental assayhost-pathogen & immune response

𝕏 PostBluesky